Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and - - PowerPoint PPT Presentation

occurrence and fate of the cytostatic drugs
SMART_READER_LITE
LIVE PREVIEW

Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and - - PowerPoint PPT Presentation

Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and Ifosfamide in Wastewater and Surface Waters Ignaz J. Buerge, Hans-Rudolf Buser, Thomas Poiger, Markus D. Mller Plant Protection Chemistry Swiss Federal Research Station


slide-1
SLIDE 1

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Ignaz J. Buerge, Hans-Rudolf Buser, Thomas Poiger, Markus D. Müller Plant Protection Chemistry Swiss Federal Research Station CH-8820 Wädenswil, Switzerland

Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and Ifosfamide in Wastewater and Surface Waters

slide-2
SLIDE 2

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

P N O H N O Cl Cl P N O N O H Cl Cl

  • cytostatic drugs
  • chemotherapy of bronchial-, brest-, ovarian-cancer,

lymphomas, leukaemias, etc.

  • immunosuppression

(rheumatoid arthritis, bone marrow transplantation) Cyclophosphamide Ifosfamide

slide-3
SLIDE 3

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

→ metabolic activation to the mustard

P HN O N Cl Cl O P H2N OH N Cl Cl O

→ unspecific alkylation e.g., cross-linking of guanine bases

N HN N N O H2N R + N NH N N NH2 O N P R H2N OH O +

→ errors in DNA replication → mutagenic, carcinogenic, teratogenic, and embryotoxic effects A T C G G C

Crick and Watson

slide-4
SLIDE 4

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

consumption/dosage trace analysis dissipation behavior

  • ccurrence in

wastewater ecotoxicity/ risk assessment

  • ccurrence in

surface waters

slide-5
SLIDE 5

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Cyclophosphamide Ifosfamide Switzerland, 2002 55 kg 12 kg Germany, (2000) 200-400 kg Austria, 1997 39 kg 18 kg treatment ambulant or clinical ambulant or clinical typical dosage ≈ 1 g ≈ 2 g renal excretion ≈ 13 % ≈ 15 %

Annual Consumption/Dosage

slide-6
SLIDE 6

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Matrix Limit of Detection untreated wastewater treated wastewater surface water 0.2-1 ng/L 0.3-0.4 ng/L 0.02-0.1 ng/L

Trace Analysis

untreated wastewater 6 ng/L spiked groundwater 0.25 ng/L

solid phase extraction analysis by LC-MS-MS → extremely sensitive analytical method

slide-7
SLIDE 7

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

  • non biodegraded in activated sludge
  • no sorption to sewage sludge (log KOW = 0.97)
  • no volatilization (KH = 7 ·10-11 atm L/mol)

→ high persistence in WWTPs

50 100 150 2 4 6 8 10 12 Incubation Time [h] Concentration [ng/L] 24 Cyclophosphamide Ifosfamide

Behavior in Wastewater Treatment Plants (WWTPs)

slide-8
SLIDE 8

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

degradation gas exchange sorption/ sedimentation sediment/water- exchange flushing

degradation processes

  • biodegradation
  • hydrolysis ?
  • photolysis ?

Behavior in Surface Waters

water exchange

slide-9
SLIDE 9

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Half-Lives under Laboratory Conditions

CP IF hydrolysis 80 d 100 d > 1 year indirect photolysis by HO· radicals 140 d

0.0 0.2 0.4 0.6 0.8 1.0 1.2 10 20 30 40 50 60 7 Incubation Time [days] Cyclophosphamide [ μg/L]

dark incubation: hydrolysis light incubation: hydrolysis and indirect photolysis

slide-10
SLIDE 10

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Extrapolation to Surface Waters

CP IF hydrolysis 1-2 years several years several years indirect photolysis by HO· radicals several years → slow degradation in surface waters primarily by hydrolysis

slide-11
SLIDE 11

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Comparison of Dissipation by Water Exchange and Hydrolysis

water exchange water exchange, hydrolysis hydrolysis CP IF

slide-12
SLIDE 12

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Degradation by Photochemically Formed HO. Radicals

  • diffusion controlled reaction
  • may be relevant only in shallow, clear, and nitrate-rich waterbodies
  • could be further exploited for elimination of CP and IF by advanced
  • xidation processes, e.g., in a treatment of hospital wastewater
slide-13
SLIDE 13

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

consumption in CH 55 kg renal excretion 13 % water consumption CH 500 L/(person day) degradation in sewer system not considered degradation in WWTPs none PEC untreated and treated wastewater CH "realistic worst case" 5.4 ng/L up to ≈ 100 ng/L

Predicted Concentrations (PEC) of Cyclophosphamide in WWTPs

slide-14
SLIDE 14

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

WWTP Männedorf

  • hospital with a relatively large oncology division
  • little dilution by domestic wastewater of 9000 inhabitants

→ "realistic worst case" situation WWTP Zürich

  • several hospitals, surgeries, where cytostatic drugs are administered
  • high dilution by domestic wastewater of 370000 inhabitants

→ typical situation for urban areas

Selection of WWTPs

slide-15
SLIDE 15

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

WWTP Influent [ng/L] Effluent [ng/L] Zürich 2-5 2-4 Männedorf (no treatment in hospital) ≈ 4 ≈ 2 Männedorf (with treatments in hospial) 11 * 10 * PEC CH 5.4 5.4 PEC "realistic worst case" up to 100 up to 100

Measured Concentrations (MEC) in WWTPs

→ persistent in WWTPs → * under dry weather conditions ≈ 40 ng/L → PEC ≈ MEC

slide-16
SLIDE 16

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Measured Concentrations in Surface Waters

PEC treated wastewater 5.4 ng/L degradation in lakes hydrolysis considered PEC lake Zurich PEC "realistic worst case" surface water 0.07-0.08 ng/L a few ng/L MEC lake Zurich ≈ 0.05-0.07 ng/L MEC river Limmat below WWTP Zürich 0.15-0.17 ng/L → PEC ≈ MEC

slide-17
SLIDE 17

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

Ecotoxicological Data: Mutagenicity to Fish

  • micronucleus test with erythrozytes of Anguilla anguilla:

3 d exposition, highest effects at 25 mg/L

  • sister chromatide exchange with Anguilla anguilla:

3 d exposition, effects in the mg/L range → toxicity-exposure ratio TER >> 1, no acute ecotoxicological risk → no ecotoxicological studies on chronic effects to aquatic organisms

Pacheco and Santos, 1996 Santos and Pacheco, 1995

slide-18
SLIDE 18

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

  • consumption CH: 55 kg CP, 12 kg IF
  • extremely sensitive analytical method: LODs down to 0.02 ng/L
  • persistent in WWTPs with activated sludge treatment
  • elimination in lakes by water exchange and slow hydrolysis
  • degradation by HO· radicals: AOP treatment of hospital

wastewater

  • MEC wastewater: 2-11 ng/L CP, < 0.3-6 ng/L IF

"realistic worst case": up to 100 ng/L

  • MEC surface waters: up to 0.17 ng/L CP, 0.14 ng/L IF

"realistic worst case": a few ng/L

  • no acute ecotoxicological risk, but no ecotoxicological studies
  • n chronic effects to aquatic organisms

Summary

Buerge et al., Environ. Sci. Technol., in prep.

slide-19
SLIDE 19

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

  • BAFU: B. Hitzfeld, U. Stämpfli, C. Studer, A. Weber
  • A. Heck: Universitätsspital Zürich
  • U. Strebel: Kreisspital Männedorf
  • T. Frösch: Bezirksspital Affoltern am Albis
  • T. Zobrist: Baxter Oncology
  • J. Weber: WWTP Männedorf
  • P. Feusi: WWTP Werdhölzli
  • Amt für Abfall, Wasser, Energie und Luft (AWEL), Zürich
  • M. Langmeier, M. Reutlinger, S. Canonica : Eawag
  • M.E. Balmer, A. Bächli, A. Hauser, B. Patrian: agroscope FAW

Acknowledgments

slide-20
SLIDE 20

Buerge I.J. et al., 1st Network Conference on Persistent Organic Pollutants: Human Exposure and Impacts, University of Birmingham, March 29-30, 2006

www.pch.faw.ch